Clinical Trial Update: Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from Massachusetts General Hospital evaluating infliximab to address cognitive dysfunction and inflammation in major depressive disorder;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Major Depressive Disorder

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depressive Disorder, Major, Inflammation | Phase 2 | Status: RECRUITING